Approach to the Patients with Elevated CA 19-9

Approach to the Patients with Elevated CA 19-9

With the widespread adoption of health check-ups, tumor markers are being used for screening healthy individuals without symptoms related to cancer. Although CA 19-9 is known to have diagnostic value when a patient presents with symptoms, the evidence for its clinical value as a cancer screening tes...

Full description

Bibliographic Details
Main Author:	Jung Wan Choe
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2023-05-01
Series:	The Korean Journal of Gastroenterology
Subjects:	ca-19-9 antigen tumor pancreatic diseases biliary tract diseases gastrointestinal diseases
Online Access:	https://www.kjg.or.kr/journal/view.html?uid=5913&vmd=Full

Similar Items

The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
by: Lenka N. C. Boyd, et al.
Published: (2022-01-01)

Significantly Elevated CA 19-9 after COVID-19 Vaccination and Literature Review of Non-Cancerous Cases with CA 19-9 > 1000 U/mL
by: Jakub Ciesielka, et al.
Published: (2024-02-01)

Pancreatic carcinoma: The contribution of CA 19-9 to the enhancement of diagnostic precision of imaging techniques
by: Trifunović Jasna, et al.
Published: (2003-01-01)

Pancreatic Tuberculosis with Markedly Elevated CA 19-9 Levels: A Diagnostic Pitfall
by: Manveen Kaur, et al.
Published: (2016-11-01)

CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma
by: Rosa Coelho, et al.
Published: (2017-02-01)

Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records
by: Mustafa Mahir Ülgü, et al.
Published: (2023-08-01)

Comparison of Urinary and Serum CA 19-9 as Markers of Early Stage Urothelial Carcinoma
by: Suparna Roy, et al.
Published: (2013-09-01)

Raised CA19-9 in Autoimmune Pancreatitis
by: Sridhar Sundaram, et al.
Published: (2020-05-01)

Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center
by: Zuowei Wu, et al.
Published: (2022-07-01)

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
by: Leilani Lakemeyer, et al.
Published: (2021-03-01)

Evaluation the Sensitivity and Specificity of CA 19-9 Test in Gastric Adenocarcinoma
by: Mohammad Jafari
Published: (2006-06-01)

Urinary Level of CA19-9 as a Tumor Marker in Urothelial Carcinoma of the Bladder
by: Keya Pal, et al.
Published: (2011-09-01)

Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer
by: Jiayu Zhang, et al.
Published: (2020-02-01)

Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
by: Mahgoub Samir S, et al.
Published: (2011-07-01)

CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer
by: Y. Chen, et al.
Published: (2019-08-01)

Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
by: Ashish Sachan, et al.
Published: (2020-08-01)

Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report
by: Minoru Kihara, et al.
Published: (2022-03-01)

Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease
by: Selcuk Şeber, et al.
Published: (2019-09-01)

Extraordinary elevated CA19-9 in patient with common bile duct stones and cholangitis Case report
by: Ali Mokhtarifar, et al.
Published: (2012-05-01)

Erratum: predictors of malignancy in pancreatic head mass: a prospective study
by: The Pan African Medical Journal
Published: (2016-03-01)

Tumor biomarkers CEA, CA19.9, CA15.3 and AFP levels in the serum of patients with COVID-19
by: Abubaker H. Ali, et al.
Published: (2022-04-01)

Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer
by: Ko Tomishima, et al.
Published: (2021-08-01)

Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy
by: Sang Hun Park, et al.
Published: (2021-06-01)

The Value of CA125 and CA19-9 in the Diagnosis of Stage Ⅲ and Ⅳ Endometriosis
by: Wenwen Zhang, et al.
Published: (2024-02-01)

Isolated CA 19-9 Elevation as Preceding Finding of Colorectal Carcinoma
by: Abdurrahman Sahin, et al.
Published: (2016-09-01)

Carbohydrate antigen 19-9-producing splenic cyst: a case report
by: Norihiro Shinkawa, MD, PhD, et al.
Published: (2022-01-01)

Single-session esophagogastroduodenoscopy and endoscopic ultrasound using a forward-viewing radial scan ultrasonic endoscope
by: Daisuke Uchida, et al.
Published: (2019-12-01)

CA19-9 and CK immunohistochemical expression in pancreatic and ampulla of vater carcinomas (A clinicopathological study
by: Sudad A. Khalf, et al.
Published: (2014-10-01)

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9
by: Roman O. Kowalchuk, et al.
Published: (2021-05-01)

Biological risk based on preoperative serum CA19‐9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcinoma
by: Shaofei Chang, et al.
Published: (2023-12-01)

Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
by: Jong Woo Lee, et al.
Published: (2021-03-01)

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer
by: Chen Liu, et al.
Published: (2023-02-01)

Splenic Epithelial Cyst with Elevated Ca 19-9 Levels
by: Sunil Kumar Shetty, et al.
Published: (2014-05-01)

Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients
by: Ailing Zhong, et al.
Published: (2019-02-01)

CA 19-9 Ölçümünde Heterofil Antikor İnterferansı: Bir Olgu Sunumu
by: Mehmet Ramazan Şekeroğlu, et al.
Published: (2019-09-01)

Akut apandisitte Ca125, CA19.9 ve karsinoembriyonik antijen gibi tümör belirteçlerinin rolü
by: Sevil Kurban, et al.
Published: (2015-09-01)

Spontaneously Ruptured Giant Splenic Cyst with Elevated Serum Levels of CA 19-9, CA 125 and Carcinoembryonic Antigen
by: Takamitsu Inokuma, et al.
Published: (2010-06-01)

Yüksek Serum CA19-9 Seviyeleri ile Seyreden Bir Endometriozis Olgusu
by: Özlem Nuray Sever, et al.
Published: (2019-03-01)

Is CA 19-9 of Any Help in the Management of Cholangiocarcinoma
by: Marília Cravo
Published: (2017-03-01)

The Role Of Tumor Markers In The Diagnosis And Follow Up In Patients With Pancreatic Cancer
by: Ansam Aladdin Al-Bayatti
Published: (2007-01-01)